Truvian is a healthcare company automating a benchtop system to produce lab-accurate results for a full-suite of health tests using a small sample of blood, providing immediate insights to inform healthcare decisions.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
02/24/2021 | Series C | $109.42MM | $xx.xx | $410.51MM | 7wireventures, Tyh Ventures, Wittington Ventures | |
Price per Share
$xx.xx
Shares Outstanding
10,527,709
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
7wireventures, Tyh Ventures, Wittington Ventures
|
||||||
11/20/2019 | Series B | $27.08MM | $xx.xx | $138.87MM | Dns Capital, Domain Associates, Greatpoint Ventures, Tao Capital Partners | |
Price per Share
$xx.xx
Shares Outstanding
5,010,592
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Dns Capital, Domain Associates, Greatpoint Ventures, Tao Capital Partners
|
||||||
01/01/2019 | Series A | $17.27MM | $xx.xx | $32.2MM | Domain Associates | |
Price per Share
$xx.xx
Shares Outstanding
10,926,918
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Domain Associates
|
||||||
09/28/2015 | Series Seed | $2MM | $xx.xx | $5.71MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,333,333
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|